National Institute for Health and Care Excellence (NICE). SonoVue (sulphur hexafluoride microbubbles) - Contrast agent for contrast-enhanced ultrasound imaging of the liver. NICE Diagnostics Guidance 5. London: NICE; 2012.
Claudon, M, Dietrich, CF, Choi, BI, et al.
Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol.
Jang, JY, Kim, MY, Jeong, SW, et al.
Current consensus and guidelines of contrast-enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol.
Friedrich-Rust, M, Klopffleisch, T, Nierhoff, J, et al.
Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: A meta-analysis. Liver Int.
Ooi, CC, Low, SC, Schneider-Kolsky, M, et al.
Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: A retrospective study. J Med Imaging Radiat Oncol.
Beaton, C, Cochlin, D, Kumar, N. Contrast-enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions. Eur J Surg Oncol.
Leen, E, Angerson, WJ, Yarmenitis, S, et al.
Multi‑centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol.
Albrecht, T, Hohmann, J, Oldenburg, A, Skrok, J, Wolf, KJ. Detection and characterisation of liver metastases. Eur Radiol.
Piscaglia, F, Bolondi, L.
Italian Society for Ultrasound in Medicine and Biology (SIUMB) study group on ultrasound contrast agents. The safety of Sonovue in abdominal applications: Retrospective analysis of 23188 investigations. Ultrasound Med Biol.
Adverse effects associated with SonoVue use. Expert Opin Drug Saf.
Sirli, R, Sporea, I, Popescu, A, et al.
Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice. Med Ultrason.
Enders, J, Zimmermann, E, Rief, M, et al.
Reduction of claustrophobia during magnetic resonance imaging: Methods and design of the “CLAUSTRO” randomized controlled trial. BMC Med Imaging. 2011;11:4.
Ollivier, L, Apiou, F, Leclère, J, et al.
Patient experiences and preferences: Development of practice guidelines in a cancer imaging department. Cancer Imaging. 2009;9:92–97.
Pahade, J, Couto, C, Davis, RB, et al.
Reviewing imaging examination results with a radiologist immediately after study completion: Patient preferences and assessment of feasibility in an academic department. AJR Am J Roentgenol.
Smith, AB, Filby, A, Carr, LM. Heterogeneity in patient diagnostic pathways: An example from contrast-enhanced ultrasound diagnostic scans for focal liver lesions. BMC Res Notes. 2012;31:199.
Lancsar, E, Louviere, J.
Conducting discrete choice experiments to inform healthcare decision making: A user's guide. Pharmacoeconomics. 2008;26:661–677.
de Bekker-Grob, EW, Ryan, M, Gerard, K.
Discrete choice experiments in health economics: A review of the literature. Health Econ.
Howard, K, Salkeld, G, Pignone, M, et al.
Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: A discrete choice experiment. Value Health. 2011;14:1146–1152.
van Dongen, H, Timmermans, A, Jacobi, CE, et al.
Diagnostic hysteroscopy and saline infusion sonography in the diagnosis of intrauterine abnormalities: An assessment of patient preference. Gynecol Surg.
Jenkinson, C, Layte, R.
Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2:14–18.
Brazier, JE, Roberts, J.
Estimating a preference-based index from the SF-12. Med Care.
Bridges, JF, Hauber, AB, Marshall, D, et al.
Conjoint analysis applications in health-a checklist: A report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14:403–413.
Econometric Software. NLOGIT. Version 5 ed.
Plainview, NY: Econometric Software, Inc.; 2012.
Westwood, M, Joore, M, Grutters, J, et al.
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: A systematic review and cost-effectiveness analysis. Health Technol Assess.